HOPA

Videos

David DeRemer, PharmD, BCOP, FCCP, FHOPA, a past-president on the board of Hematology/Oncology Pharmacy Association (HOPA), discusses why a greater focus on colorectal cancer screening was important to highlight at the HOPA 2022 annual conference.

HOPA Past President: Research Assessing the Microbiome in Colorectal Cancer Is Emerging Daily, May Have Significant Impact to the Field

David DeRemer, PharmD, BCOP, FCCP, FHOPA, a past-president on the board of Hematology/Oncology Pharmacy Association (HOPA), discusses key takeaways from the HOPA 2022 annual conference.

HOPA Past President: In-Person Conferences Help Pharmacists Disengage From Distractions, Delve Into Educational Content, Professional Development

Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses how experience as a caregiver can help inform the work of an oncology pharmacist on the clinical care team.

How Caring for a Loved One With Cancer Can Inform Oncology Pharmacists’ Role on the Clinical Care Team

Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses how oncology pharmacists with experience as a caregiver can utilize those skills while still honoring the boundaries of both themselves and their patients.

Expert: For Oncology Pharmacists, It’s Critical to ‘Not Forget to Invest in Ourselves Because We're So Busy Caring for Other People’

Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the unique struggles that come from being an oncology pharmacist and a caregiver.

The Unique Struggles of Being Both an Oncology Pharmacist, Caregiver for a Loved One With Cancer

Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses how oncology pharmacists can help their patients overcome some of the barriers patients with cancer may encounter during treatment.

Assessing Oncology Pharmacists’ Responsibility to Help Patients With Cancer Overcome Barriers to Care, Treatment

Benyam Muluneh, PharmD, BCOP, CPP, assistant professor at the University of North Carolina Eshelman School of Pharmacy, discusses his presentation at the HOPA 2022 annual conference on the Oral Chemotherapy Collaborative (OCC) and how it works to optimize care for patients taking oral anti-cancer agents.

Expert: Critical to Establish ROI Model for Value of Clinical Pharmacists So All Patients Have a Pharmacist on Oncology Care Team

Britny Brown, PharmD, BCOP, vice chair of the Hematology/Oncology Pharmacy Association (HOPA) DEI Task Force and clinical assistant professor at the University of Rhode Island College of Pharmacy, discusses the role of the task force within HOPA and its impact on the field more broadly.

Expert: Addressing Diversity, Equity, Inclusion Is an Opportunity, a Priority for HOPA Moving Forward

Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the barriers patients with cancer may experience that oncology pharmacists can help them navigate through.

How Oncology Pharmacists Can Provide Support, Address Barriers to Care for Patients With Cancer

Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the barriers that patients with cancer may encounter following their diagnosis.